Tuck S, Morselli P, Broquaire M, Vert P
J Pediatr. 1983 Sep;103(3):481-5. doi: 10.1016/s0022-3476(83)80433-8.
Plasma and urinary furosemide kinetics were assayed by high-power liquid chromatography in six newborn infants receiving furosemide (1 mg/kg body weight IV) for the treatment of fluid overload. Mean +/- SD for plasma half-life, apparent volume of distribution, and plasma clearance were, respectively, 9.5 +/- 4.4 hours, 173 +/- 28 ml/kg, and 15.3 +/- 8.4 ml/hr/kg. There was close correspondence between plasma and urinary half-lives and between plasma clearance and renal clearance. In the first 24 hours, mean estimated urinary recovery of unchanged furosemide was 90% of the injected dose (range 61% to 106%). The results suggest that in the newborn infant furosemide is virtually all excreted unchanged in the urine and that the absence of significant nonrenal elimination, together with the immaturity of neonatal renal function, accounts for its prolonged half-life in newborn infants.
采用高效液相色谱法对6名接受呋塞米(静脉注射1mg/kg体重)治疗液体超负荷的新生儿进行血浆和尿液呋塞米动力学分析。血浆半衰期、表观分布容积和血浆清除率的平均值±标准差分别为9.5±4.4小时、173±28ml/kg和15.3±8.4ml/小时/kg。血浆和尿液半衰期之间以及血浆清除率和肾清除率之间存在密切对应关系。在最初24小时内,未改变的呋塞米平均估计尿回收率为注射剂量的90%(范围为61%至106%)。结果表明,在新生儿中,呋塞米几乎全部以原形经尿液排泄,并且缺乏显著的非肾清除以及新生儿肾功能不成熟导致了其在新生儿中半衰期延长。